[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353402-105":59,"doc-detail-353402-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oncogenic-dnmt3b-as-a-therapeutic-target-for-cervical-cancer-research-paper-summary","Oncogenic DNMT3B as a therapeutic target for cervical cancer - Research paper summary","","Epigenetic-related genes play a pivotal role in cancer development and progression, yet their value for cervical cancer diagnosis and prognosis remains insufficiently explored. Clinical data and gene expression profiles were collected from public databases, epigenetic associations were modeled using LASSO Cox regression, and multiple algorithms evaluated links between epigenetic-related genes and immune responses, treatment outcomes, and predictive performance. DNMT3B was selected for validation, and protein and gene expression assays were used alongside in vitro and in vivo experiments.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oncogenic-dnmt3b-as-a-therapeutic-target-for-cervical-cancer-research-paper-summary/353402/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oncogenic-dnmt3b-as-a-therapeutic-target-for-cervical-cancer-research-paper-summary/353402.png","ImageObject",300,407,{"name":92,"@type":93},"mieayamfan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of integrating epigenetic-related genes in this study?","Question",{"text":112,"@type":113},"To build robust prognostic signatures for predicting overall survival and treatment outcomes in cervical cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were epigenetic associations and gene impacts evaluated?",{"text":117,"@type":113},"Epigenetic associations were predicted using LASSO Cox regression, and multiple algorithms assessed effects on immune responses, treatment outcomes, and predictive accuracy.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports DNMT3B as a therapeutic target?",{"text":121,"@type":113},"DNMT3B was found to be highly expressed in cervical cancer, and both in vitro and in vivo experiments confirmed it promotes tumor growth.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353402,1792178652,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Original Article  \nOncogenic DNMT3Bas a therapeutic target for cervical cancer  \nXuefen Lin1,2, Jianfeng Zheng1, Yanhong Li1, Siping Wang1, Qinying Liu2, Lijun Chen1, Sang Li1, Yang Sun1,2  \n1Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014, China;  \n2Fujian Provincial Key Laboratory of Tumor Biotherapy, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014, China.  \nAbstract  \nBackground: Epigenetic-related genes (ERGs) play a pivotal role in cancer development and progression. However, their potential for cervical cancer (CC) diagnosis and prognosis remains underexplored.  \nMethods: Clinical data and gene expression profiles were sourced from publicly available databases. Epigenetic associations were predicted using the least absolute shrinkage and selection operator (LASSO) Cox regression model, and multiple algorithms were employed to evaluate the impact of ERGs on immune responses, treatment outcomes, and predictive accuracy. Western blotting analysis and quantitative real-time polymerase chain reaction were used to assess gene expression. Subsequently, DNMT3B was selected for further in vitro and in vivo study.  \nResults: A total of 567 ERGs were identified from open-access databases, with 59 found to be significantly associated with prognosis of CC. Five ERGs (DNMT3B, SMYD2, IKZF3, L3MBTL2, and CHD7) were deemed instrumental in constructing a prognostic signature for CC. The predictive accuracy of the ERG signature was evaluated, revealing a robust correlation between immune cell infiltration, immunotherapy response, drug sensitivity, and the ERG signature. DNMT3B was found to be highly expressed in CC, and both in vitro and in vivo experiments confirmed its role in promoting tumor growth.  \nConclusions: The epigenetic signature developed in this study holds considerable promise for prognostic prediction and therapeutic guidance in patients with CC. DNMT3B was identified as an oncogenic gene, highlighting its potential as a therapeutic target. Keywords: Cervical cancer; Epigenetic-related genes; ERG; Prognosis; DNMT3B  \nIntroduction  \nCervical cancer (CC), a leading cause of cancer-related deaths among women, particularly in low-and middle-income countries, remains a critical public health concern. [1] Despite the availability of prophylactic vaccines targeting high-risk human papillomavirus (HPV) types, the primary etiological agents in most CC cases, both incidence and mortality rates remain high. [2] Persistent high-risk HPV infections can drive the transformation of normal cervical epithelial cells into cancerous cells, a process influenced by both genetic and epigenetic factors. [3]  \nEpigenetics refers to heritable changes in gene expression that occur without alterations to the DNA sequence. [4] These modifications, such as histone alterations, DNA methylation, and noncoding RNA (ncRNA)-mediated gene silencing, can impact critical biological processes involved in the cancer development, including cell cycle regulation, apoptosis, and DNA repair. [5] In CC, epigenetic modifications may either silence tumor suppressor genes or activate oncogenes, playing a pivotal role in the disease’s initiation and progression. [6]  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code: | Website:\u003Cbr>[www.cmj.org](www.cmj.org) |\n|  | DOI:\u003Cbr>10.1097/CM9.0000000000004130 |\n\nRecent studies highlight the importance of epigenetic changes in CC development, revealing that abnormal DNA methylation and histone modifications are linked to the malignant transformation of HPV-infected cells. [7] For example, DNA methylation of tumor suppressor genes, such as CADM1, MAL, and FAM19A4, has emerged as a potential biomarker for the early detection of CC and its precursors. [7–9] Similarly, CC cells exhibit altered histone modification patterns that influence genes involved in apoptosis, metastasis, and c","cbCaigBt69MyY5Zc","https://ap.wps.com/l/cbCaigBt69MyY5Zc","pdf",20672924,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n# Methods\n## Data collection","[{\"question\":\"What was the main goal of integrating epigenetic-related genes in this study?\",\"answer\":\"To build robust prognostic signatures for predicting overall survival and treatment outcomes in cervical cancer patients.\"},{\"question\":\"How were epigenetic associations and gene impacts evaluated?\",\"answer\":\"Epigenetic associations were predicted using LASSO Cox regression, and multiple algorithms assessed effects on immune responses, treatment outcomes, and predictive accuracy.\"},{\"question\":\"What evidence supports DNMT3B as a therapeutic target?\",\"answer\":\"DNMT3B was found to be highly expressed in cervical cancer, and both in vitro and in vivo experiments confirmed it promotes tumor growth.\"}]","Oncogenic DNMT3B as a therapeutic target for cervical cancer - Research paper summary | PDF",1790105140,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f550b6653952945ce7ad176ea4cb924.webp",983,1324,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dba05f43f37227c4ec9c007e1deae06c.webp",982,1323,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/585ac3acd4e091496455409e25eb9e9f.webp",981,1321,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56105fb0d08ad15d73cae661b8a9fd90.webp",980,1320]